Similar results were found in prostate cancer [12] as well as in endometrial cancer, where KCa3.1 showed expression levels that were higher in tumor than in normal tissues, but that were also higher in cancer than in atypical hyperplasia [13]. Here, KCNN4 is linked to prostate carcinoma.